Akari Therapeutics, Plc Stock-Based Compensation
Akari Therapeutics, Plc (AKTX) reported Stock-Based Compensation of $1.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- Akari Therapeutics, Plc share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $711.00K, a 1.11% decline year-over-year.
- Akari Therapeutics, Plc share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $305.00K, a 69.95% decline year-over-year.
- Akari Therapeutics, Plc share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $471.00K, a 62.50% decline year-over-year.
- Akari Therapeutics, Plc share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $685.00K, a 176.21% increase year-over-year.
- Akari Therapeutics, Plc share-based payment arrangement, noncash expense for fiscal 2025 was $2.89M, a 28.73% increase from fiscal 2024.
- Akari Therapeutics, Plc share-based payment arrangement, noncash expense for fiscal 2024 was $2.25M, a 95.22% increase from fiscal 2023.
- Akari Therapeutics, Plc share-based payment arrangement, noncash expense for fiscal 2023 was $1.15M.
- Akari Therapeutics, Plc share-based payment arrangement, noncash expense for fiscal 2013 was $94.00K, a 81.71% decline from fiscal 2012.
| Period end | Share-based Payment Arrangement, Noncash Expense 1 month | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 4 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 8 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed | Share-based Payment Arrangement, Noncash Expense 15 month | Share-based Payment Arrangement, Noncash Expense 99 month | Share-based Payment Arrangement, Noncash Expense 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $711.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.02M 10-Q · filed 2026-08-13 | $1.49M derived: sum of 3 quarters · filed 2026-08-13 | $2.17M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||
| 2026-03-31 | $305.00K 10-Q · filed 2026-05-19 | $776.00K derived: sum of 2 quarters · filed 2026-05-19 | $1.46M derived: sum of 3 quarters · filed 2026-05-19 | $2.18M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||
| 2025-12-31 | $471.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.16M derived: sum of 2 quarters · filed 2026-03-30 | $1.88M derived: sum of 3 quarters · filed 2026-08-13 | $2.89M 10-K · filed 2026-03-30 | |||||||||
| 2025-09-30 | $685.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.40M derived: sum of 2 quarters · filed 2026-08-13 | $2.42M 10-Q · filed 2025-11-13 | $3.67M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||
| 2025-06-30 | $719.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.73M 10-Q · filed 2026-08-13 | $2.99M derived: sum of 3 quarters · filed 2026-08-13 | $3.24M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||
| 2025-03-31 | $1.01M 10-Q · filed 2026-05-19 | $2.27M derived: sum of 2 quarters · filed 2026-05-19 | $2.52M derived: sum of 3 quarters · filed 2026-05-19 | $2.96M derived: sum of 4 quarters · filed 2026-05-19 | |||||||||
| 2024-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.50M derived: sum of 2 quarters · filed 2026-03-30 | $1.95M derived: sum of 3 quarters · filed 2026-03-30 | $2.25M 10-K · filed 2026-03-30 | |||||||||
| 2024-09-30 | $248.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $693.00K derived: sum of 2 quarters · filed 2025-11-13 | $989.00K 10-Q · filed 2025-11-13 | $1.29M derived: sum of 4 quarters · filed 2025-11-13 | |||||||||
| 2024-06-30 | $445.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $741.00K 10-Q · filed 2025-08-13 | $1.04M derived: sum of 3 quarters · filed 2025-08-13 | $1.59M derived: sum of 4 quarters · filed 2025-08-13 | |||||||||
| 2024-03-31 | $296.00K 10-Q · filed 2025-05-14 | $600.00K derived: sum of 2 quarters · filed 2025-05-14 | $1.15M derived: sum of 3 quarters · filed 2025-05-14 | $1.18M derived: sum of 4 quarters · filed 2025-05-14 | |||||||||
| 2023-12-31 | $304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $851.56K derived: sum of 2 quarters · filed 2025-04-15 | $885.00K derived: sum of 3 quarters · filed 2025-04-15 | $1.15M 10-K · filed 2025-04-15 | |||||||||
| 2023-09-30 | $547.56K derived: 10-Q 9 month − 8-K 6 month · filed 2024-11-19 | $581.00K derived: sum of 2 quarters · filed 2024-11-19 | $846.00K 10-Q · filed 2024-11-19 | ||||||||||
| 2023-06-30 | $33.44K derived: 8-K 6 month − 10-Q 3 month · filed 2024-09-06 | $298.44K 8-K · filed 2024-09-06 | $541.53K 6-K · filed 2023-09-29 | ||||||||||
| 2023-03-31 | $265.00K 10-Q · filed 2024-05-15 | ||||||||||||
| 2022-12-31 | $560.06K 8-K · filed 2024-09-06 | $735.11K 20-F · filed 2023-05-01 | |||||||||||
| 2022-06-30 | $221.69K 6-K · filed 2023-09-29 | ||||||||||||
| 2021-12-31 | $314.65K 20-F · filed 2023-05-01 | ||||||||||||
| 2021-06-30 | $166.99K 6-K · filed 2022-09-27 | ||||||||||||
| 2020-12-31 | $80.58K derived: 20-F 12 month − 20-F 9 month · filed 2023-05-01 | $161.69K derived: sum of 2 quarters · filed 2023-05-01 | $225.02K derived: sum of 3 quarters · filed 2023-05-01 | $325.52K 20-F · filed 2023-05-01 | |||||||||
| 2020-09-30 | $81.11K derived: 20-F 9 month − 6-K 6 month · filed 2021-04-21 | $144.44K derived: sum of 2 quarters · filed 2021-09-22 | $244.94K 20-F · filed 2021-04-21 | $350.88K derived: sum of 4 quarters · filed 2022-05-16 | |||||||||
| 2020-06-30 | $63.33K derived: 6-K 6 month − 20-F 3 month · filed 2021-09-22 | $163.83K 6-K · filed 2021-09-22 | $269.77K derived: sum of 3 quarters · filed 2022-05-16 | $407.16K derived: sum of 4 quarters · filed 2022-05-16 | |||||||||
| 2020-03-31 | $100.50K 20-F · filed 2021-04-21 | $206.44K derived: sum of 2 quarters · filed 2022-05-16 | $343.83K derived: sum of 3 quarters · filed 2022-05-16 | $753.45K derived: sum of 4 quarters · filed 2022-05-16 | |||||||||
| 2019-12-31 | $105.94K derived: 20-F 12 month − 20-F 9 month · filed 2022-05-16 | $243.33K derived: sum of 2 quarters · filed 2022-05-16 | $652.95K derived: sum of 3 quarters · filed 2022-05-16 | $1.05M 20-F · filed 2022-05-16 | |||||||||
| 2019-09-30 | $137.38K derived: 20-F 9 month − 20-F 6 month · filed 2021-04-21 | $547.01K derived: sum of 2 quarters · filed 2021-04-21 | $941.45K 20-F · filed 2021-04-21 | ||||||||||
| 2019-06-30 | $409.62K derived: 20-F 6 month − 20-F 3 month · filed 2021-04-21 | $804.06K 20-F · filed 2021-04-21 | |||||||||||
| 2019-03-31 | $394.44K 20-F · filed 2021-04-21 | ||||||||||||
| 2018-12-31 | $1.65M 20-F · filed 2021-04-21 | ||||||||||||
| 2018-06-30 | $827.94K 6-K · filed 2019-08-29 | ||||||||||||
| 2017-12-31 | $2.73M 20-F · filed 2020-03-31 | ||||||||||||
| 2017-06-30 | $1.75M 6-K · filed 2018-09-27 | ||||||||||||
| 2016-12-31 | $3.93M 20-F · filed 2019-04-23 | ||||||||||||
| 2016-06-30 | $805.41K derived: 6-K 6 month − 10-Q 3 month · filed 2017-08-10 | $1.62M 6-K · filed 2017-08-10 | $2.59M derived: sum of 3 quarters · filed 2018-07-18 | $2.66M derived: sum of 4 quarters · filed 2018-07-18 | |||||||||
| 2016-03-31 | $816.80K 10-Q · filed 2016-05-12 | $1.78M derived: sum of 2 quarters · filed 2018-07-18 | $1.86M derived: sum of 3 quarters · filed 2018-07-18 | $1.86M derived: sum of 4 quarters · filed 2018-07-18 | |||||||||
| 2015-12-31 | $963.80K derived: 20-F 12 month − 10-Q 9 month · filed 2018-07-18 | $1.04M derived: sum of 2 quarters · filed 2018-07-18 | $1.04M derived: sum of 3 quarters · filed 2018-07-18 | $1.04M 20-F · filed 2018-07-18 | |||||||||
| 2015-09-30 | $76.06K derived: 10-Q 9 month − 6-K 6 month · filed 2015-11-23 | $76.06K derived: sum of 2 quarters · filed 2017-04-14 | $76.06K 10-Q · filed 2015-11-23 | $76.06K derived: sum of 4 quarters · filed 2017-04-14 | |||||||||
| 2015-06-30 | $0.00 derived: 6-K 6 month − 10-Q 3 month · filed 2017-04-14 | $0.00 6-K · filed 2017-04-14 | $108.00K 10-Q · filed 2015-08-12 | $0.00 derived: sum of 3 quarters · filed 2017-04-14 | -$351.00K derived: sum of 4 quarters · filed 2017-04-14 | ||||||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-12 | $59.00K 10-Q · filed 2015-05-12 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | -$351.00K derived: sum of 3 quarters · filed 2017-03-31 | -$195.00K derived: sum of 4 quarters · filed 2017-03-31 | ||||||||
| 2014-12-31 | $0.00 derived: 20-F 12 month − 10-Q 9 month · filed 2017-03-31 | -$351.00K derived: sum of 2 quarters · filed 2017-03-31 | -$195.00K derived: sum of 3 quarters · filed 2017-03-31 | $0.00 20-F · filed 2017-03-31 | $468.00K 10-K · filed 2015-02-11 | ||||||||
| 2014-09-30 | -$351.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-23 | -$195.00K derived: sum of 2 quarters · filed 2015-11-23 | $0.00 10-Q · filed 2015-11-23 | ||||||||||
| 2014-08-30 | $2.00K 10-K · filed 2015-02-11 | ||||||||||||
| 2014-06-30 | $156.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $351.00K 10-Q · filed 2015-08-12 | |||||||||||
| 2014-03-31 | $195.00K 10-Q · filed 2015-05-12 | ||||||||||||
| 2013-12-31 | $94.00K 10-K · filed 2015-02-11 | $1.62M 20-F · filed 2014-03-24 | |||||||||||
| 2012-12-31 | $514.00K 10-K · filed 2015-02-11 | $1.53M 20-F/A · filed 2013-04-19 | |||||||||||
| 2012-08-31 | $120.00K 10-K · filed 2015-02-11 | ||||||||||||
| 2012-06-30 | $2.00K 20-F · filed 2014-03-24 | ||||||||||||
| 2011-12-31 | $140.00K 20-F · filed 2014-03-24 | ||||||||||||
| 2010-12-31 | $0.00 20-F/A · filed 2013-04-19 | ||||||||||||
| 2009-12-31 | $70.00K 20-F/A · filed 2013-04-19 | ||||||||||||
| 2008-12-31 | $168.00K 20-F/A · filed 2013-04-19 | ||||||||||||
| 2007-12-31 | $448.00K 20-F/A · filed 2013-04-19 | ||||||||||||
| 2006-12-31 | $69.00K 20-F/A · filed 2013-04-19 | ||||||||||||
| 2005-12-31 | $119.00K 20-F/A · filed 2013-04-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |